Zurich Cantonal Bank’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Zurich Cantonal Bank’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,585	Closed	-$156K	–	2684
2024 Q2	$156K	Hold	4,585	–	–	﹤0.01%	2157
2024 Q1	$161K	Hold	4,585	–	–	﹤0.01%	2175
2023 Q4	$132K	Sell	4,585 -1,597	-26%	-$38K	﹤0.01%	2312
2023 Q3	$142K	Buy	6,182 +1,705	+38%	+$89.5K	﹤0.01%	2176
2023 Q2	$257K	Buy	4,477 +2,203	+97%	+$115K	﹤0.01%	1756
2023 Q1	$85.6K	Hold	2,274	–	–	﹤0.01%	2373
2022 Q4	$60.8K	Hold	2,274	–	–	﹤0.01%	2537
2022 Q3	$64K	Buy	2,274 +2,106	+1,254%	+$58.7K	﹤0.01%	2505
2022 Q2	$4K	Buy	+168	New	+$4.69K	﹤0.01%	2882

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Zurich Cantonal Bank's MORF Position: Q3 2024 in Review

Zurich Cantonal Bank sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 4,585 shares — an estimated $156K sold.

Zurich Cantonal Bank first reported a position in MORF in Q2 2022 and held it in 9 quarters. The position peaked at $257K in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

Zurich Cantonal Bank reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Zurich Cantonal Bank sold 4,585 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $156K.
Zurich Cantonal Bank first reported a position in Morphic Holding, Inc. Common Stock in Q2 2022 and held it in 9 quarters.
Zurich Cantonal Bank's Morphic Holding, Inc. Common Stock position peaked at $257K in Q2 2023.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Zurich Cantonal Bank's 13F filing for Q3 2024, filed 8 Nov 2024.